News & Blog

MaxWell Biosystems at venture leaders Life Science 2017 in Boston

From the 12th to the 16th of June MaxWell Biosystems and other nine Swiss Life Science startups participated in the business-boosting venture leaders Life Science program, held in Boston. It was an inspiring week, co-organized by swissnex Boston, with pitching events, company visits, and meetings with VCs and experts. Indeed, it was a great opportunity for the ten selected startups to take the first steps towards global expansion. The ten startups met medtech and biotech industry experts who gave motivating feedback on different aspects of business development. The…

Read More

MaxWell Biosystems wins Venture Kick

MaxWell Biosystems passes the final stage of Venture Kick and wins CHF 100’000. After presenting at the final stage, MaxWell Biosystems convinced the Venture Kick jury and secured CHF 100’000, in addition to CHF 30’000 already granted in previous stages. Venture Kick supports the first steps of the realization of a business idea and awards selected start-ups with up to CHF 130’000 seed money. The final stage serves as the culmination of the year-long journey of MaxWell Biosystems with Venture Kick. The journey started last July…

Read More

MaxWell Biosystems featured in ETH News

MaxWell Biosystems gets more media coverage. ETH Zurich News features the spin-off company MaxWell Biosystems. The article highlights the company’s core technology developed in Hierlemann Lab (D-BSSE) and the motivation to commercialize thanks to the demand of induced pluripotent stem cell boom. Link to English version >> Link to German version >>

Read More

MaxWell Biosystems as a nominee for De Vigier Award 2017

MaxWell Biosystems was successfully preselected as one of the 10 nominees for the W. A. De Vigier Stiftung award. The Award Ceremony will take place in Solothurn on the 18th of May 2017. The William A. De Vigier foundation provides assistance to young Switzerland entrepreneurs. Since its 28th anniversary, the foundation has distributed over 10 million francs of start-up capital.

Read More
Contacts








Mattenstrasse 26
4058 Basel, Switzerland

+41 44 244 24 24

+41 61 551 10 71

info@mxwbio.com